{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:57:18Z","timestamp":1789102638199,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["88887.703845\/2022\\u201300"],"award-info":[{"award-number":["88887.703845\/2022\\u201300"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S001026\/1"],"award-info":[{"award-number":["MR\/S001026\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V036904\/1"],"award-info":[{"award-number":["MR\/V036904\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88881.506794\/2020\\u201301"],"award-info":[{"award-number":["88881.506794\/2020\\u201301"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.506792\/2020\\u201300"],"award-info":[{"award-number":["88887.506792\/2020\\u201300"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-02148-21"],"award-info":[{"award-number":["APQ-02148-21"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-01487-22"],"award-info":[{"award-number":["APQ-01487-22"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-04686-22"],"award-info":[{"award-number":["APQ-04686-22"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["67355"],"award-info":[{"award-number":["67355"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["88887.700246\/2022-00"],"award-info":[{"award-number":["88887.700246\/2022-00"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["142495\/2020-4"],"award-info":[{"award-number":["142495\/2020-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.biochi.2025.04.006","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T11:50:40Z","timestamp":1745581840000},"page":"39-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Bothropstoxins I and II as potent phospholipase A2 molecules from Bothrops jararacussu to impair hepatitis C virus infection"],"prefix":"10.1016","volume":"235","author":[{"given":"Carina Machado","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline Farinha","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha Marques","family":"Cassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor Andrade","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cintia","family":"Bittar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e9lia Cristina","family":"Oliveira Cintra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suely Vilela","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Rahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"Gomes Jardim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biochi.2025.04.006_bib1","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/hep.20819","article-title":"Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes","volume":"42","author":"Simmonds","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biochi.2025.04.006_bib2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/jhep.2000.19150","article-title":"Hepatitis C virus resistance to antiviral therapy","volume":"32","author":"Pawlotsky","year":"2016","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.biochi.2025.04.006_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1478-3231.2008.01925.x","article-title":"Discovery of the hepatitis C virus","volume":"29","author":"Houghton","year":"2009","journal-title":"Liver Int."},{"issue":"43","key":"10.1016\/j.biochi.2025.04.006_bib4","first-page":"15992","article-title":"Hepatitis C virus molecular evolution : transmission , disease progression and antiviral therapy","volume":"20","author":"Preciado","year":"2014"},{"issue":"6","key":"10.1016\/j.biochi.2025.04.006_bib5","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/hep.510280632","article-title":"Prognosis of chronic hepatitis C: results of a large, prospective cohort study","volume":"28","author":"Niederau","year":"1998","journal-title":"Hepatology"},{"issue":"27","key":"10.1016\/j.biochi.2025.04.006_bib6","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1038\/sj.onc.1209562","article-title":"Viral hepatitis and liver cancer: the case of hepatitis C","volume":"25","author":"Levrero","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.biochi.2025.04.006_bib7","unstructured":"WHO. Hepatitis C. WHO."},{"issue":"1","key":"10.1016\/j.biochi.2025.04.006_bib8","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.biochi.2025.04.006_bib9","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cmi.2016.07.035","article-title":"Hepatitis C: global epidemiology and strategies for control","volume":"22","author":"Lanini","year":"2016","journal-title":"Clin. Microbiol. Infection"},{"issue":"11","key":"10.1016\/j.biochi.2025.04.006_bib10","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1128\/JVI.00250-12","article-title":"Serology-enabled discovery of genetically diverse hepaciviruses in a new host","volume":"86","author":"Burbelo","year":"2012","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.biochi.2025.04.006_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/hep.27440","article-title":"Clinical course of infection and viral tissue tropism of hepatitis C virus-like nonprimate hepaciviruses in horses","volume":"61","author":"Pfaender","year":"2015","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.biochi.2025.04.006_bib12","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.3201\/eid1812.120498","article-title":"Nonprimate hepaciviruses in domestic horses, United Kingdom","volume":"18","author":"Lyons","year":"2012","journal-title":"Emerg. Infect. Dis."},{"issue":"3","key":"10.1016\/j.biochi.2025.04.006_bib13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.tvjl.2015.10.015","article-title":"Identification of two phylogenetic lineages of equine hepacivirus and high prevalence in Brazil","volume":"206","author":"Figueiredo","year":"2015","journal-title":"Vet. J."},{"issue":"5","key":"10.1016\/j.biochi.2025.04.006_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155662","article-title":"First description of hepacivirus and pegivirus infection in domestic horses in China: a study in guangdong province, heilongjiang province and Hong Kong district","volume":"11","author":"Lu","year":"2016","journal-title":"PLoS One"},{"issue":"3\u20134","key":"10.1016\/j.biochi.2025.04.006_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.vetmic.2015.05.028","article-title":"Genetic and serological surveillance for non-primate hepacivirus in horses in Japan","volume":"179","author":"Matsuu","year":"2015","journal-title":"Vet. Microbiol."},{"issue":"2","key":"10.1016\/j.biochi.2025.04.006_bib16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s40471-017-0108-x","article-title":"Review of the epidemiology, clinical care, and continued challenges in the direct-acting antiviral era","volume":"4","author":"Millman","year":"2017","journal-title":"Curr. Epidemiol. Rep."},{"key":"10.1016\/j.biochi.2025.04.006_bib17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12876-015-0320-4","article-title":"Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US","volume":"15","author":"Zhang","year":"2015","journal-title":"BMC Gastroenterol."},{"issue":"March","key":"10.1016\/j.biochi.2025.04.006_bib18","first-page":"1","article-title":"Evolution of multi-drug resistant HCV clones from pre-existing resistant-associated variants during direct-acting antiviral therapy determined by third-generation sequencing","author":"Takeda","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biochi.2025.04.006_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.toxicon.2020.10.014","article-title":"Potent virucidal activity of honeybee \u201cApis mellifera\u201d venom against Hepatitis C Virus","volume":"188","author":"Sarhan","year":"2020","journal-title":"Toxicon"},{"issue":"12","key":"10.1016\/j.biochi.2025.04.006_bib20","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s12275-016-6376-1","article-title":"Inhibitory effects of bee venom and its components against viruses in vitro and in vivo","volume":"54","author":"Uddin","year":"2016","journal-title":"J. Microbiol."},{"key":"10.1016\/j.biochi.2025.04.006_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12985-015-0276-6","article-title":"Virocidal activity of Egyptian scorpion venoms against hepatitis C virus","volume":"12","author":"El-Bitar","year":"2015","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.biochi.2025.04.006_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.peptides.2010.10.008","article-title":"A new natural \u03b1-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV","volume":"32","author":"Yan","year":"2011","journal-title":"Peptides (NY)"},{"issue":"7","key":"10.1016\/j.biochi.2025.04.006_bib23","first-page":"10548","article-title":"APOBEC3A possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer","volume":"8","author":"Chen","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.biochi.2025.04.006_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114105","article-title":"Snake venom three-finger toxins and their potential in drug development targeting cardiovascular diseases","volume":"181","author":"Kini","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.biochi.2025.04.006_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2023.140930","article-title":"Bothrops atrox venom: biochemical properties and cellular phenotypes of three highly toxic classes of toxins","volume":"1871","author":"Lopes-de-Souza","year":"2023","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"issue":"2","key":"10.1016\/j.biochi.2025.04.006_bib26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.bcp.2008.05.003","article-title":"Antiviral and antiparasite properties of an l-amino acid oxidase from the Snake Bothrops jararaca: cloning and identification of a complete cDNA sequence","volume":"76","author":"Sant'Ana","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.biochi.2025.04.006_bib27","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3851\/IMP2291","article-title":"Contortrostatin, a homodimeric disintegrin isolated from snake venom inhibits herpes simplex virus entry and cell fusion","volume":"17","author":"Hubbard","year":"2012","journal-title":"Antivir. Ther."},{"issue":"11","key":"10.1016\/j.biochi.2025.04.006_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0112351","article-title":"Phospholipase A2 isolated from the venom of Crotalus durissus terrificus inactivates dengue virus and other enveloped viruses by disrupting the viral envelope","volume":"9","author":"Muller","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biochi.2025.04.006_bib29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.toxicon.2011.05.021","article-title":"Crotoxin and phospholipases A 2 from Crotalus durissus terrificus showed antiviral activity against dengue and yellow fever viruses","volume":"59","author":"Muller","year":"2012","journal-title":"Toxicon"},{"issue":"11","key":"10.1016\/j.biochi.2025.04.006_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187857","article-title":"Multiple effects of toxins isolated from Crotalus durissus terrificus on the hepatitis C virus life cycle","volume":"12","author":"Shimizu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biochi.2025.04.006_bib31","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ijbiomac.2022.12.102","article-title":"Roles of Bothrops jararacussu toxins I and II: antiviral findings against Zika virus","volume":"227","author":"Cassani","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.biochi.2025.04.006_bib32","first-page":"1","article-title":"Broad-spectrum antiviral agents: secreted phospholipase A2 targets viral envelope lipid bilayers derived from the endoplasmic reticulum membrane","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.biochi.2025.04.006_bib33","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1073\/pnas.68.7.1560","article-title":"Biological roles of the two components of crotoxin","volume":"68","author":"Hendon","year":"1971","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2025.04.006_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124519","article-title":"Effect of proteins isolated from Brazilian snakes on enterovirus A71 replication cycle: an approach against hand, foot and mouth disease","volume":"241","author":"Shimizu","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.biochi.2025.04.006_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF01024915","article-title":"Bothropstoxin-I: amino acid sequence and function","volume":"12","author":"Cintra","year":"1993","journal-title":"J. Protein Chem."},{"issue":"4","key":"10.1016\/j.biochi.2025.04.006_bib36","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1023\/A:1022563401413","article-title":"The amino acid sequence of bothropstoxin-II, an Asp-49 myotoxin from Bothrops jararacussu (Jararacucu) venom with low phospholipase A2 activity","volume":"17","author":"Pereira","year":"1998","journal-title":"J. Protein Chem."},{"issue":"5259","key":"10.1016\/j.biochi.2025.04.006_bib37","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.biochi.2025.04.006_bib38","doi-asserted-by":"crossref","first-page":"13001","DOI":"10.1128\/JVI.76.24.13001-13014.2002","article-title":"Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication","volume":"76","author":"Blight","year":"2002","journal-title":"J. Virol."},{"issue":"1\u20132","key":"10.1016\/j.biochi.2025.04.006_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.biochi.2025.04.006_bib40","series-title":"Multiple Effects of Toxins Isolated from Crotalus durissus Terrificus on the Hepatitis C Virus Life Cycle","author":"Farinha Shimizu","year":"2017"},{"issue":"7","key":"10.1016\/j.biochi.2025.04.006_bib41","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.biochi.2025.04.006_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2014.12.018","article-title":"Natural compounds isolated from Brazilian plants are potent inhibitors of hepatitis C virus replication in vitro","volume":"115","author":"Jardim","year":"2015","journal-title":"Antivir. Res."},{"issue":"3","key":"10.1016\/j.biochi.2025.04.006_bib43","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/hep.24803","article-title":"(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry","volume":"55","author":"Calland","year":"2012","journal-title":"Hepatology"},{"issue":"20","key":"10.1016\/j.biochi.2025.04.006_bib44","doi-asserted-by":"crossref","first-page":"17775","DOI":"10.1074\/jbc.M210900200","article-title":"The hepatitis C virus non-structural NS5A protein inhibits activating protein-1 function by perturbing Ras-ERK pathway signaling","volume":"278","author":"Macdonald","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biochi.2025.04.006_bib45","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/hep.23281","article-title":"Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A","volume":"50","author":"Ciesek","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biochi.2025.04.006_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-09741-5","article-title":"Efficacy and safety of the sofosbuvir\/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19","volume":"12","author":"Messina","year":"2022","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biochi.2025.04.006_bib47","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein\u2013protein docking","volume":"15","author":"Yan","year":"2020","journal-title":"Nat. Protoc."},{"issue":"11","key":"10.1016\/j.biochi.2025.04.006_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."},{"issue":"10","key":"10.1016\/j.biochi.2025.04.006_bib49","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.biochi.2025.04.006_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6841628","article-title":"Recent advances in antiviral therapy for chronic hepatitis C","volume":"2016","author":"Tamori","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biochi.2025.04.006_bib51","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2017.07.015","article-title":"Immunogenicity of an influenza virus-vectored vaccine carrying the hepatitis C virus protein epitopes in mice","volume":"145","author":"Zhang","year":"2017","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.biochi.2025.04.006_bib52","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s13337-021-00697-0","article-title":"Current therapeutics against HCV","volume":"32","author":"Bhattacharjee","year":"2021","journal-title":"Virusdisease"},{"issue":"1","key":"10.1016\/j.biochi.2025.04.006_bib53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.biochi.2025.04.006_bib54","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.3390\/v7072809","article-title":"Genetic diversity underlying the envelope glycoproteins of hepatitis C virus: structural and functional consequences and the implications for vaccine design","volume":"7","author":"Tarr","year":"2015","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.biochi.2025.04.006_bib55","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.toxicon.2008.10.002","article-title":"Interspecific variation in venom composition and toxicity of Brazilian snakes from Bothrops genus","volume":"52","author":"Queiroz","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.biochi.2025.04.006_bib56","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.toxicon.2015.07.004","article-title":"Synthesis and characterization of an antibacterial and non-toxic dimeric peptide derived from the C-terminal region of Bothropstoxin-I","volume":"103","author":"Santos-Filho","year":"2015","journal-title":"Toxicon"},{"issue":"11","key":"10.1016\/j.biochi.2025.04.006_bib57","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.bbalip.2006.07.011","article-title":"The phospholipase A2 superfamily and its group numbering system","volume":"1761","author":"Schaloske","year":"2006","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"8","key":"10.1016\/j.biochi.2025.04.006_bib58","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.toxicon.2003.11.002","article-title":"Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes","volume":"42","author":"Kini","year":"2003","journal-title":"Toxicon"},{"issue":"10","key":"10.1016\/j.biochi.2025.04.006_bib59","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.biochi.2003.09.011","article-title":"Isolation, characterization and biological activity of acidic phospholipase A2 isoforms from Bothrops jararacussu snake venom","volume":"85","author":"Ketelhut","year":"2003","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/j.biochi.2025.04.006_bib60","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.toxicon.2004.06.008","article-title":"Bactericidal and neurotoxic activities of two myotoxic phospholipases A2 from Bothrops neuwiedi pauloensis snake venom","volume":"44","author":"Rodrigues","year":"2004","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.biochi.2025.04.006_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-88039-4","article-title":"Chikungunya virus entry is strongly inhibited by phospholipase A2 isolated from the venom of Crotalus durissus terrificus","volume":"11","author":"Santos","year":"2021","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.biochi.2025.04.006_bib62","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2174\/092986608785849245","article-title":"Biochemical and structural investigations of Bothropstoxin-II, a myotoxic Asp49 phospholipase A2 from Bothrops jararacussu venom","volume":"15","author":"Murakami","year":"2008","journal-title":"Protein Pept. Lett."},{"issue":"8","key":"10.1016\/j.biochi.2025.04.006_bib63","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1107\/S1744309106025164","article-title":"Preliminary X-ray crystallographic studies of BthTX-II, a myotoxic Asp49-phospholipase A2with low catalytic activity from Bothrops jararacussu venom","volume":"62","author":"Corr\u00eaa","year":"2006","journal-title":"Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun."},{"issue":"4","key":"10.1016\/j.biochi.2025.04.006_bib64","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.toxicon.2009.05.025","article-title":"The interaction of bothropstoxin-I (Lys49-PLA2) with liposome membranes","volume":"54","author":"Ferreira","year":"2009","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/j.biochi.2025.04.006_bib65","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/(SICI)1097-0134(19980301)30:4<442::AID-PROT11>3.0.CO;2-I","article-title":"Crystallographic and spectroscopic characterization of a molecular hinge: conformational changes in Bothropstoxin I, a dimeric Lys49- phospholipase A2 homologue","volume":"30","author":"Da Silva Giotto","year":"1998","journal-title":"Protein Struct. Funct. Genet."},{"issue":"1","key":"10.1016\/j.biochi.2025.04.006_bib66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/abbi.1999.1492","article-title":"Structural and functional characterization of myotoxin I, a Lys49 phospholipase A(2) homologue from Bothrops moojeni (Caissaca) snake venom","volume":"373","author":"Soares","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"issue":"8","key":"10.1016\/j.biochi.2025.04.006_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110859","article-title":"Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening","volume":"39","author":"Pfaff-Kilgore","year":"2022","journal-title":"Cell Rep."},{"issue":"February","key":"10.1016\/j.biochi.2025.04.006_bib68","first-page":"1","article-title":"Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's disease","volume":"5","author":"Hajj","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biochi.2025.04.006_bib69","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1306218","article-title":"Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection","volume":"370","author":"Sulkowski","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"00","key":"10.1016\/j.biochi.2025.04.006_bib70","first-page":"1","article-title":"Sofosbuvir + velpatasvir + voxilaprevir for the treatment of hepatitis C infection","volume":"00","author":"Cory","year":"2018","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.biochi.2025.04.006_bib71","series-title":"Hepacivirus hominis [Internet]","year":"2024"},{"key":"10.1016\/j.biochi.2025.04.006_bib72","series-title":"Hepatitis C [Internet]","year":"2024"},{"issue":"4","key":"10.1016\/j.biochi.2025.04.006_bib73","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1023\/A:1022563401413","article-title":"The amino acid sequence of Bothropstoxin-II, an Asp-49 myotoxin from Bothrops jararacussu (Jararacucu) venom with low phospholipase A2 activity","volume":"17","author":"Pereira","year":"1998","journal-title":"J. Protein. Chem."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908425000811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908425000811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:35:17Z","timestamp":1762284917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908425000811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":73,"alternative-id":["S0300908425000811"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2025.04.006","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bothropstoxins I and II as potent phospholipase A2 molecules from Bothrops jararacussu to impair hepatitis C virus infection","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2025.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}